Human megakaryocytes possess intrinsic antiviral immunity through regulated induction of IFITM3
Robert A. Campbell(Children's Health Queensland Hospital and Health Service), Matthew T. Rondina(University of Utah), Cassandra H. Ventrone(University of Vermont), Bhanu Kanth Manne(University of Utah), Emilie Montenont(University of Utah), Seema Bhatlekar(University of Utah), Andrew S. Weyrich(Oklahoma Medical Research Foundation), Robert Hunter-Mellado(Central University of the Caribbean), Paul F. Bray(University of Southampton), Yasuhiro Kosaka(University of Utah), Jesse W. Rowley(University of Utah), Stephen S. Whitehead(National Institutes of Health), Patrı́cia T. Bozza(Fundação Oswaldo Cruz), Neal D. Tolley(University of Utah), Alicia S. Eustes(University of Iowa), Fernando A. Bozza(D’Or Institute for Research and Education), Hansjörg Schwertz(University of Utah), A. Valance Washington(Oakland University), Eugênio D. Hottz(Universidade Federal de Juiz de Fora), Sean A. Diehl(University of Vermont), Miles Christensen, Guy A. Zimmerman(University of Utah), Kristen K. Pierce(Loyola University Medical Center), Beth D. Kirkpatrick(University of Vermont)
Cited by 192
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α
|Journal of Biological Chemistry|2001|968
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Prospects for a dengue virus vaccine
|Nature Reviews Microbiology|2007|624